Citadel Advisors’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-355,203
| Closed | -$130K | – | 13131 |
|
|
2025
Q2 | $130K | Buy |
+355,203
| New | +$119K | ﹤0.01% | 11090 |
|
|
2025
Q1 | – | Sell |
-266,243
| Closed | -$152K | – | 14775 |
|
|
2024
Q4 | $150K | Buy |
+266,243
| New | +$157K | ﹤0.01% | 10885 |
|
|
2024
Q3 | – | Sell |
-40,113
| Closed | -$59.5K | – | 14501 |
|
|
2024
Q2 | $108K | Sell |
40,113
-1,529,451
| -97% | -$5.76M | ﹤0.01% | 10809 |
|
|
2024
Q1 | $8.05M | Buy |
1,569,564
+978,081
| +165% | +$3.17M | 0.01% | 3229 |
|
|
2023
Q4 | $318K | Sell |
591,483
-248,718
| -30% | -$132K | ﹤0.01% | 9051 |
|
|
2023
Q3 | $557K | Buy |
840,201
+1,607
| +0.2% | +$1.63K | ﹤0.01% | 7828 |
|
|
2023
Q2 | $1.27M | Buy |
+838,594
| New | +$2.21M | ﹤0.01% | 5958 |
|
|
2022
Q1 | – | Sell |
-21,856
| Closed | -$132K | – | 13864 |
|
|
2021
Q4 | $132K | Buy |
+21,856
| New | +$151K | ﹤0.01% | 12426 |
|
